Dallas 3/2/2011 8:07:21 AM
News / Finance

BIDZ, TAN, FFHL, VSR, APRI: Stocks With Light Volume But Increased Activity

Stocks With Light Volume But Increased Activity: BIDZ, TAN, FFHL, VSR, APRI

Bidz.com (NASDAQ:BIDZ) has gained 0.62% or one cent a share to settle at $1.61 with a volume of 71,000 shares. For the past 52 weeks the stock has been trading between $1.10 and $2.50 a share with an average volume of 60,800. Market capitalization of the for the company is $31.4 million.

BIDZ.com, Inc. is an online retailer of jewelry, featuring a live auction format. The Company offers offer its products through a live format, featuring a $1 minimum opening bid, and a 15-second auction period that allows its auctions to continue until all bids are received. On select auctions it maintains a reserve price that must be met before a sale will be consummated. The majority of its auctions are short-term, often lasting less than one hour.

Guggenheim Solar ETF (NYSE:TAN) has lost 1.58% or $.13 a share to settle at $8.08 with a volume of 1.6 million shares. For the past 52 weeks the stock has been trading between $6.02 and $9.34 with an average volume of 550,000 shares. This fund has a net assets of $165 million with a trailing 12 months P/E ratio of 14.

The Fund seeks investment results that correspond generally to the performance, before the Fund's fees and expenses, of an equity index called the MAC Global Solar Energy Index.

Fuwei Films (Holdings) Co. (NASDAQ:FFHL) has lost 0.2% or one cents a share to settle at $5.07 with a moderate volume of 106,400 shares. For the past 52 weeks the stock has been trading between $.78 and $6.55 and an average volume of 105,000 shares. The company market capitalization is $66 million with a trailing 12 month P/E ratio of 27.41

Fuwei Films (Holding) Co., Ltd. (Fuwei) develops, manufactures and distributes plastic film using the biaxially oriented stretch technique, known as BOPET film (Biaxially oriented polyethylene terephthalate). The film is light-weight, non-toxic, odorless, transparent, glossy, temperature and moisture-resistant, and retains high barrier resistance, making it suitable for many forms of flexible packaging, printing, laminating, aluminum-plating and other applications.

Versar, Inc. (AMEX:VSR) has lost 2.5% or nine cents a share to settle at $3.51 with a volume of 48,000 shares. For the past 52 weeks the stock has been trading between $1.98 and $4.74 with an average volume of 28,000 shares. Company market capitalization is $32.6 million.

Versar, Inc. (Versar), is a project management company that provides solutions to government and commercial clients in construction management, environmental services, munitions response, telecommunications and energy. Versar provides solutions in harsh environments and offers specialized abilities in rapid response, classified projects and hazardous material management. Versar operates in four business segments: Program Management, Compliance and Environmental Programs, Professional Services, and National Security. In January 2010, the Company acquired Professional Protection Systems, Ltd. (PPS).

Apricus Biosciences Inc. (NASDAQ:APRI) has lost 4.48% or $.24 to settle at $5.12 a share with a increased volume of 990,000 shares. For the past 52 weeks the stock has been trading between $1.60 and $9.30 a share with an average volume of 780,000 shares. Company has a market capitalization of $66 million.

Apricus Biosciences, Inc., formerly NexMed, Inc., is a pharmaceutical research and development company focused on the design and development of products and technologies in multiple therapeutic areas, including oncology, sexual dysfunction, autoimmune diseases and pain/inflammation. Its drug delivery technology is called NexACT. The Company has two operating segments: designing and developing pharmaceutical products (The NexACT drug delivery technology business) and providing pre-clinical CRO services (The Bio-Quant CRO business).

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report